Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Foray

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Cancers|September 28, 2024
Prediction of Cancer Proneness under Influence of X-rays with Four DNA Mutability and/or Three Cellular Proliferation AssaysLaura El Nachef, Larry Bodgi, Maxime Estavoyer, et al.
Cancer Research|June 18, 2003
Synchrotron photoactivation of cisplatin elicits an extra number of DNA breaks that stimulate RAD51-mediated repair pathwaysStéphanie Corde, Jacques Balosso, Hélène Elleaume, et al.
BMC Medicine|September 2, 2017
A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypesJean-Philippe Foy, Louis Bazire, Sandra Ortiz-Cuaran, et al.
International Journal of Molecular Sciences|July 20, 2021
Human Radiosensitivity and Radiosusceptibility: What Are the Differences?Laura El-Nachef, Joelle Al-Choboq, Juliette Restier-Verlet, et al.
Cancers|August 12, 2023
Influence of the Hypersensitivity to Low Dose Phenomenon on the Tumor Response to Hypofractionated Stereotactic Body Radiation TherapyEymeric Le Reun, Adeline Granzotto, Adeline Pêtre, et al.
International Journal of Molecular Sciences|September 23, 2022
Quantitative Correlations between Radiosensitivity Biomarkers Show That the ATM Protein Kinase Is Strongly Involved in the Radiotoxicities Observed after RadiotherapyEymeric Le Reun, Larry Bodgi, Adeline Granzotto, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2016
The Henri Mondor Procedure of Morbidity and Mortality Review Meetings: Prospective Registration of Clinical, Dosimetric, and Individual Radiosensitivity Data of Patients With Severe Radiation ToxicityYazid Belkacemi, Laurianne Colson-Durand, Adeline Granzotto, et al.
Molecular Neurobiology|November 2, 2021
Individual Response to Radiation of Individuals with Neurofibromatosis Type I: Role of the ATM Protein and Influence of Statins and BisphosphonatesPatrick Combemale, Laurène Sonzogni, Clément Devic, et al.
Tumori|May 17, 2022
Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot studySophie Deneuve, Thierry Bastogne, Mirlande Duclos, et al.
Nature Medicine|July 1, 2008
Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature agingIgnacio Varela, Sandrine Pereira, Alejandro P Ugalde, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Cancers|September 28, 2024
Prediction of Cancer Proneness under Influence of X-rays with Four DNA Mutability and/or Three Cellular Proliferation AssaysLaura El Nachef, Larry Bodgi, Maxime Estavoyer, et al.
Cancer Research|June 18, 2003
Synchrotron photoactivation of cisplatin elicits an extra number of DNA breaks that stimulate RAD51-mediated repair pathwaysStéphanie Corde, Jacques Balosso, Hélène Elleaume, et al.
BMC Medicine|September 2, 2017
A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypesJean-Philippe Foy, Louis Bazire, Sandra Ortiz-Cuaran, et al.
International Journal of Molecular Sciences|July 20, 2021
Human Radiosensitivity and Radiosusceptibility: What Are the Differences?Laura El-Nachef, Joelle Al-Choboq, Juliette Restier-Verlet, et al.
Cancers|August 12, 2023
Influence of the Hypersensitivity to Low Dose Phenomenon on the Tumor Response to Hypofractionated Stereotactic Body Radiation TherapyEymeric Le Reun, Adeline Granzotto, Adeline Pêtre, et al.
International Journal of Molecular Sciences|September 23, 2022
Quantitative Correlations between Radiosensitivity Biomarkers Show That the ATM Protein Kinase Is Strongly Involved in the Radiotoxicities Observed after RadiotherapyEymeric Le Reun, Larry Bodgi, Adeline Granzotto, et al.
International Journal of Radiation Oncology, Biology, Physics|September 30, 2016
The Henri Mondor Procedure of Morbidity and Mortality Review Meetings: Prospective Registration of Clinical, Dosimetric, and Individual Radiosensitivity Data of Patients With Severe Radiation ToxicityYazid Belkacemi, Laurianne Colson-Durand, Adeline Granzotto, et al.
Molecular Neurobiology|November 2, 2021
Individual Response to Radiation of Individuals with Neurofibromatosis Type I: Role of the ATM Protein and Influence of Statins and BisphosphonatesPatrick Combemale, Laurène Sonzogni, Clément Devic, et al.
Tumori|May 17, 2022
Predicting acute severe toxicity for head and neck squamous cell carcinomas by combining dosimetry with a radiosensitivity biomarker: a pilot studySophie Deneuve, Thierry Bastogne, Mirlande Duclos, et al.
Nature Medicine|July 1, 2008
Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature agingIgnacio Varela, Sandrine Pereira, Alejandro P Ugalde, et al.
Pageof 10